Why the study?
Do plasma neuropeptide Y levels correlate with indices of reperfusion and coronary microvascular resistance in patients with STEMI undergoing primary PCI?
Do plasma neuropeptide Y levels correlate with indices of reperfusion and coronary microvascular resistance in patients with STEMI undergoing primary PCI?
Elevated plasma neuropeptide Y levels during STEMI correlate with impaired reperfusion and higher coronary microvascular resistance following primary PCI.
No takes yet. Share an insight, caveat, or question.
NPY may flag microvascular risk in STEMI; hypothesis-generating and requires prospective validation before clinical use.
Cuculi et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: